Medacta H1 2026 revenue up; EBITDA margin 27.8% constant-currency
Medacta Group says H1 2026 revenue rose nearly 10% to EUR 368 million. Adjusted EBITDA margin was 27.8% at constant currency. Guidance for 10%-14% revenue growth and margin expansion is confirmed.